Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - Heart, 2017 - heart.bmj.com
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

[引用][C] Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - Heart, 2017 - researchportal.helsinki.fi
Improvement of myocardial infarction risk prediction via inflammation-associated metabolite
biomarkers — University of Helsinki Skip to main navigation Skip to search Skip to main …

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - Heart, 2017 - heart.bmj.com
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

[HTML][HTML] Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund… - Heart (British Cardiac …, 2017 - ncbi.nlm.nih.gov
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - Heart, 2017 - diva-portal.org
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

[引用][C] Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - 2017 - oparu.uni-ulm.de

[PDF][PDF] Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - 2017 - researchgate.net
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

CK Ward-Caviness, T Xu, T Aspelund, B Thorand… - 2017 - mediatum.ub.tum.de
The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

CK Ward-Caviness, XT Xu Tao, T Aspelund, B Thorand… - 2017 - cabidigitallibrary.org
Objective: The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

CK Ward-Caviness, T Xu, T Aspelund… - Heart (British Cardiac …, 2017 - europepmc.org
Objective The comprehensive assaying of low-molecular-weight compounds, for example,
metabolomics, provides a unique tool to uncover novel biomarkers and understand …